This study presents novel data regarding the expression of FBN1 (the gene encoding profibrillin-1), asprosin (the novel orexigenic/glucogenic hormone which is cleaved from profibrillin-1), and OR4M1 (the human cognate receptor of asprosin) in cancer, focusing on ovarian cancer. Here, OR4M1 is linked to cancer.